|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,130 KRW | -3.95% |
|
-8.02% | -30.12% |
| 2023 | Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS | CI |
| 2023 | Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers | CI |
Dx & Vx Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 0.00015 million. Net loss was KRW 779.65 million compared to KRW 7,269.28 million a year ago.
Basic loss per share from continuing operations was KRW 54 compared to KRW 276 a year ago. Basic loss per share was KRW 27 compared to KRW 298 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.12% | 91.56M | |
| -27.66% | 9.88B | |
| +26.94% | 2.89B | |
| -15.73% | 2.12B | |
| -20.83% | 1.67B | |
| +67.18% | 1.45B | |
| +26.08% | 788M | |
| -4.15% | 741M | |
| -28.78% | 514M | |
| +3.98% | 308M |
DX & VX CO., LTD. 
